International Congress of Mucosal Immunology

描述（由申请人提供）： 每四年一次，从事粘膜免疫研究的科学家社区在国际粘膜免疫大会（ICMI）上召开会议，以深入了解他们的科学领域。第12届国际大会将于2005年6月25日至30日在马萨诸塞州波士顿的Marriott Copley Square酒店举行，由Lloyd Mayer博士和Richard Blumberg博士领导的粘液免疫学会主办。本次会议将在四天的时间内举行，每天都集中在粘膜免疫学家感兴趣的主要科学领域之一。这包括专门讨论先天性和适应性免疫、粘膜对感染的反应和疫苗开发以及与异常免疫反应有关的粘膜表面疾病的天数。会议的每一天将开始与全体会议，其中两个杰出的科学家内外的粘膜免疫领域将发言。随后将举行以与会者提交的摘要为中心的专题讨论会/海报讨论会。最后，每一天都将以杰出的免疫学家的演讲结束，他们将总结各自感兴趣的领域与粘膜免疫相关的研究。大会将集中讨论粘膜免疫的基本主题，包括口服耐受、粘膜反应的调节、抗原呈递和粘膜免疫系统中的B细胞功能。此外，它将检查由于粘膜免疫功能障碍引起的疾病，包括炎症性肠病，哮喘和螺旋杆菌感染等重大疾病。最后，它将主要关注粘膜疫苗的开发，特别是因为这阐明了HIV疫苗的研究。总的来说，大会是粘膜免疫知识景观的主要和必要的组成部分。

DESCRIPTION (provided by applicant): Once every four years, the community of scientists engaged in mucosal immunity research convene at the International Congress of Mucosal Immunity (ICMI) to obtain an in-depth overview of their scientific area. The 12th such International Congress will be held in Boston MA on June 25th-30th, 2005 at the Marriott Copley Square Hotel and is being organized under the auspices of the Society for Mucosal Immunity led by Drs. Lloyd Mayer and Richard Blumberg. This meeting will occur over a four day period, each day focused on one of the major scientific areas of interest to mucosal immunologists. This includes days devoted to innate and adaptive immunity, mucosal responses to infections and vaccine development and diseases of mucosal surfaces related to abnormal immune responses. Each day of the meeting will begin with plenary sessions in which both outstanding scientists outside and inside the area of mucosal immunity will speak. These will be followed by Symposia/poster discussion sessions centered on abstracts submitted by meeting participants. Finally, each day will end with addresses from outstanding immunologists who will sum up research in their respective areas of interest with relevance to mucosal immunity. The Congress will focus on basic themes of mucosal immunity including oral tolerance, regulation of mucosal responses, antigen presentation and B cell function in the mucosal immune system. In addition, it will examine diseases due to mucosal immune dysfunction including such major diseases as inflammatory bowel diseases, asthma, and helicobactor infection. Finally, it will devote major attention to mucosal vaccine development, particularly as this elucidates the search for a HIV vaccine. Overall, the Congress is a major and necessary part of the intellectual landscape of mucosal immunity.